event · 25 July 1959 · 66 years ago
Lloyd J. Old introduced BCG, a tuberculosis vaccine, into experimental cancer research as a way to stimulate non-specific resistance to tumor growth. BCG was FDA-approved in 1991 and is now widely used as a first line treatment for superficial bladder cancer.